International immunologists unveil MIATA Project

The Cancer Research Institute, a U.S.-based nonprofit organization dedicated to harnessing the power of the immune system to treat, control and prevent cancer, and the Association for Cancer Immunotherapy, a European nonprofit organization based in Mainz, Germany, that aims to foster the development of cancer immunotherapies, announce the launch of a global, broad-based initiative to improve the reliability of reports of data derived from T cell-based immune monitoring assays, especially those used in the study of therapeutic vaccines for cancer and infectious diseases. Read more about the MIATA Project.

Related Summaries